Schedule 13G ownership disclosure

Dyne Therapeutics Inc

Security class unavailable · CUSIP: 26818M108

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,326,117
Percent of class
9.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-012942
Form type
SC 13G/A
Filer
Atlas Venture Fund XI, L.P.
CIK
CIK 1708269
Filed
Feb 09, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub